forbot
India
Velpanat buy in Ahmedabad
Currency INR
Velpanat buy in Ahmedabad
Buy Velpanat
Velpanat

Velpanat

ID: 91045: 702984
Products from producer
In stock
Reconfirm the price with seller
0UAH
+91( 
Display phones
Do you have any questions about the product/service?
Please, leave your inquiry and company manager will contact you.
India, Ahmedabad
Less than 1 year old on Allbiz
Technical characteristics
  • BrandVelpanat
  • Country of manufactureIndia
Description

Velpanat
Packing: 1*28 Tablet
Company: Gilead
Contain : Sofosbuir 400mg & Velpatasvir 100mg

Velpanat by Natco contain Sofosbuvir 400mg and Velpatasvir 100mg . Velpanat is generic of EPCLUSA.


Natco's Velpanat is use for the treatment of Hepatitis C. Hepatitis C is a liver disease caused by the hepatitis C virus the virus can cause both acute and chronic hepatitis infection, ranging in severity from a mild illness lasting a few weeks to a serious, lifelong illness.

 

There is currently no vaccine for hepatitis C; however research in this area is ongoing.

The hepatitis C virus is a bloodborne virus. It is most commonly transmitted through:

 # injecting drug use through the sharing of injection equipment;

 # The reuse or inadequate sterilization of medical equipment, especially syringes and needles in healthcare settings; and the transfusion of unscreened blood and blood products.

 Velpanat contain Sofosbuvir & Velpatasvir . Sofosbuvir is a HCV nucleotide analog NS5B polymerase inhibitor and Velpatasvir is hepatitis C virus NS5A inhibitor . Velpanat is indicated for the treatment of Chronic Hepatitis  genotype 1,2,3,4,5,6 infection.

The Clinical trail of Epclusa (Astral Trail) was conducted.  And the SVR after 12 week was studies in all HCV genotype patient. In the Genotype 1 patient without cirrhosis or with compensated cirrhosis SVR was 98 to 99%.  In Genotype 2 patient SVR was found 99%, In Genotype 3 SVR was 95% And in genotype 4 and 6 SVR was 100% And 95% in Genotype 5.

In Decompensated Cirrhosis after 12week therapy Sofosbuvir + Velpatasvir in combination with Ribavarin SVR was found 94%.

SVR meaning no detectable of HCV virus after 12 week of treatment.

Dosage:

The recommended dose of Velpanat tablet once daily , taken orally, with or without food .

The recommended dose of Velpanat ( Sofosbuvir + Velpatasvir ) is as below.

The dose of Epclusa In Genotype 1,2,3,4,5,6  without cirrhosis And Patient with compensated cirrhosis is 12 weeks without Ribavarin.

The dose of Velpanat In Genotype 1,2,3,4,5,6 Patient  with decompensated cirrhosis is 12 weeks with Ribavarin

Adverse Reaction:

Most common adverse reactions  observed with Velpanat is headache , Fatigue , Asthenia , Nausia, Headache ,insomnia , diarrhea.

Storage : Velpnat should be stored below temperature 30°C.

Side Effect:

Most common side effect with Velpanat  is tiredness , headache , weakness, confusion, memory problems ,

 

Velpanat should be taken on Doctor prescription only.

K M Healthcare is trader , exporter, supplier of Velapnat Tablet at very economical price.

Velpanat In India , Natco Velpanat , Natco’s Sofosbuvir and Velpatasavir.

Velpatasvir and Sofosbuvir supplier from India, Hpecinat Lp Supplier

We are Supplier & Exporter of Velpanat to the patient and many country. We supply it to county like Russia, Romania, Ukraine, Belarus, Uzbekistan , Cambodia ,  Singapore,China , Minsk , Armenia , Europe Germany , London, Switzerland , France, Denmark, Barcelona, Spain, Austria,   Australia, Africa , Newzeland , Vietnam , Hongkong, Japan,  Australia , Afghanistan , Maldova , Iran, Dubai , Philippines, Thailand , Malaysia , Indonesia,  Uk , London ,Germany and many more countries and Cities.

Contact the seller
Velpanat
Velpanat
for
by the goods
Your message must contain at least 20 symbols. The message must not be more than 2000 symbols.
Obligatory field is not filled
The field is wrongly filled
The field is wrongly filled
Compare0
ClearSelected items: 0
    Placing, selling, advertising and/or realization of this service/product is prohibited by operating legislation. Go to main page